Nova Mentis Life Stock Net Income

NMLSF Stock  USD 0.08  0.0005  0.61%   
As of the 14th of February 2026, Nova Mentis secures the Downside Deviation of 11.85, mean deviation of 3.99, and Risk Adjusted Performance of 0.0922. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Nova Mentis Life, as well as the relationship between them. Please verify Nova Mentis Life jensen alpha, potential upside, as well as the relationship between the Potential Upside and skewness to decide if Nova Mentis Life is priced some-what accurately, providing market reflects its recent price of 0.0827 per share. As Nova Mentis Life appears to be a penny stock we also strongly suggest to check its total risk alpha numbers.
Nova Mentis' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Nova Mentis' valuation are provided below:
Nova Mentis Life does not presently have any fundamental ratios for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
  
It's important to distinguish between Nova Mentis' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Nova Mentis should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Nova Mentis' market price signifies the transaction level at which participants voluntarily complete trades.

Nova Mentis 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nova Mentis' pink sheet what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nova Mentis.
0.00
11/16/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/14/2026
0.00
If you would invest  0.00  in Nova Mentis on November 16, 2025 and sell it all today you would earn a total of 0.00 from holding Nova Mentis Life or generate 0.0% return on investment in Nova Mentis over 90 days. Nova Mentis Life Science Corp., through its subsidiaries, engages in developing diagnostics and psilocybin based therape... More

Nova Mentis Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nova Mentis' pink sheet current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nova Mentis Life upside and downside potential and time the market with a certain degree of confidence.

Nova Mentis Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Nova Mentis' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nova Mentis' standard deviation. In reality, there are many statistical measures that can use Nova Mentis historical prices to predict the future Nova Mentis' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Nova Mentis' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.000.086.50
Details
Intrinsic
Valuation
LowRealHigh
0.000.066.48
Details

Nova Mentis February 14, 2026 Technical Indicators

Nova Mentis Life Backtested Returns

Nova Mentis appears to be out of control, given 3 months investment horizon. Nova Mentis Life has Sharpe Ratio of 0.14, which conveys that the firm had a 0.14 % return per unit of risk over the last 3 months. By analyzing Nova Mentis' technical indicators, you can evaluate if the expected return of 0.88% is justified by implied risk. Please exercise Nova Mentis' Mean Deviation of 3.99, downside deviation of 11.85, and Risk Adjusted Performance of 0.0922 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Nova Mentis holds a performance score of 10. The company secures a Beta (Market Risk) of -1.26, which conveys a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Nova Mentis are expected to decrease by larger amounts. On the other hand, during market turmoil, Nova Mentis is expected to outperform it. Please check Nova Mentis' potential upside, as well as the relationship between the skewness and day median price , to make a quick decision on whether Nova Mentis' current price movements will revert.

Auto-correlation

    
  -0.02  

Very weak reverse predictability

Nova Mentis Life has very weak reverse predictability. Overlapping area represents the amount of predictability between Nova Mentis time series from 16th of November 2025 to 31st of December 2025 and 31st of December 2025 to 14th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nova Mentis Life price movement. The serial correlation of -0.02 indicates that only 2.0% of current Nova Mentis price fluctuation can be explain by its past prices.
Correlation Coefficient-0.02
Spearman Rank Test-0.13
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, Nova Mentis Life reported net income of (2.68 Million). This is 100.79% lower than that of the Healthcare sector and 103.83% lower than that of the Biotechnology industry. The net income for all United States stocks is 100.47% higher than that of the company.

Nova Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Mentis' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Nova Mentis could also be used in its relative valuation, which is a method of valuing Nova Mentis by comparing valuation metrics of similar companies.
Nova Mentis is currently under evaluation in net income category among its peers.

Nova Fundamentals

About Nova Mentis Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Nova Mentis Life's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Mentis using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Mentis Life based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in Nova Pink Sheet

Nova Mentis financial ratios help investors to determine whether Nova Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Mentis security.